|Title:||Estimating Risk Parameters|
|Abstract:||Over the last three decades, the capital asset pricing model has occupied a central and often controversial place in most corporate finance analysts’ tool chests. The model requires three inputs to compute expected returns – a riskfree rate, a beta for an asset and an expected risk premium for the market portfolio (over and above the riskfree rate). Betas are estimated, by most practitioners, by regressing returns on an asset against a stock index, with the slope of the regression being the beta of the asset. In this paper, we attempt to show the flaws in regression betas, especially for companies in emerging markets. We argue for an alternate approach that allows us to estimate a beta that reflect the current business mix and financial leverage of a firm.|
|Appears in Collections:||Credit & Debt Markets|
Items in FDA are protected by copyright, with all rights reserved, unless otherwise indicated.